Abstract
Objective
This study aimed to examine whether rheumatoid arthritis (RA) is causally associated with Alzheimer’s disease (AD).
Methods
We performed a two-sample Mendelian randomization (MR) analysis using the inverse-variance weighted (IVW), weighted median, and MR-Egger regression methods. We used the publicly available summary statistics datasets from three-stage trans-ethnic genome-wide association studies (GWAS) meta-analyses of 29,880 RA cases and 73,758 controls as exposures and a meta-analysis of 4 GWAS datasets consisting of 17,008 AD cases and 37,154 controls of European descent as outcomes.
Results
We selected 80 single nucleotide polymorphisms (SNPs) from GWAS data on RA as instrumental variables (IVs), 60 of which were associated with RA on a genome-wide significance level. The IVW method showed evidence to support an inverse causal association between RA and AD (β = −0.039, standard error [SE] = 0.017, P = 0.021). MR-Egger regression revealed that directional pleiotropy was unlikely to be a source of bias in the results (intercept = 0.002; P = 0.649). The MR-Egger analysis showed no causal association between RA and AD (β = −0.050, SE = 0.030, P = 0.096). However, the weighted median approach showed that RA and AD were causally linked (β = −0.078, SE = 0.024, P = 0.001). The funnel plot did not show heterogeneity between IV estimates based on the individual variants.
Conclusions
The MR analysis supports that RA was causally associated with a reduced risk of AD.
Zusammenfassung
Ziel
Die vorliegende Studie zielte darauf ab zu untersuchen, ob rheumatoide Arthritis (RA) in einem kausalen Zusammenhang mit M. Alzheimer stehe.
Methoden
Dazu wurde die Analyse einer 2‑Stichproben-Mendel-Randomisierung (MR) unter Einsatz von Verfahren mit inverser Varianzgewichtung (IVW), gewichtetem Mittel und der MR-Egger-Regression durchgeführt. Die Autoren verwendeten die Metaanalysen der öffentlich zugänglichen zusammenfassenden statistischen Datensätze von dreistufigen transethnischen genomweiten Assoziationsstudien (GWAS) mit 29.880 RA-Fällen und 73.758 Kontrollen als Exposition und eine Metaanalyse von 4 GWAS-Datensätzen mit 17.008 AD(Alzheimer’s disease)-Fällen und 37.154 Kontrollen europäischer Abstammung als Endpunkte.
Ergebnisse
Als instrumentelle Variablen (IV) wurden 80 Einzelnukleotidpolymorphismen (SNPs) aus den GWAS-Daten zur RA ausgewählt, von denen 60 auf einem genomweiten Signifikanzniveau mit RA assoziiert waren. Die IVW-Methode erbrachte Belege für die Stützung eines inversen Kausalzusammenhangs zwischen RA und AD (β = −0,039; Standardfehler, „standard error“, SE: 0,017, p = 0,021). Anhand der MR-Egger-Regression zeigte sich, dass es unwahrscheinlich war, dass die direktionale Pleiotropie eine Quelle für Bias in den Ergebnissen darstellte („intercept“ = 0,002; p = 0,649). Die MR-Egger-Analyse ergab keinen Kausalzusammenhang zwischen RA und AD (β = −0,050; SE = 0,030; p = 0,096). Allerdings zeigte der Ansatz unter Verwendung des gewichteten Mittels, dass RA und AD kausal verknüpft waren (β = −0,078; SE = 0,024; p = 0,001). Der Funnel Plot ergab keine Heterogenität zwischen IV-Schätzwerten auf der Basis der individuellen Varianten.
Schlussfolgerung
Die MR-Analyse lieferte Hinweise darauf, dass die RA kausal mit einem verminderten Risiko für M. Alzheimer verknüpft sei.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by inflammatory changes in the synovial membranes and articular structures leading to bone structure damage, causing disability and a decreased quality of life [9, 21]. Alzheimer’s disease (AD) is a complex, progressive, and irreversible neurodegenerative disease of the brain, which is also the most common form of dementia, a general term for memory loss and other cognitive impairments that interfere with daily life [18]. Although the etiologies of RA and AD are not fully understood, it is known that both diseases undergo an inflammatory process, while the pathogenesis of Alzheimer’s disease is multifactorial [13]. The deregulation of multiple genetic and environmental factors involved in the inflammatory cascade is a common feature in both RA and AD [11, 12].
An inverse relationship between RA and AD has been previously reported, but the evidence is inconsistent [27]. Meta-analyses of observational studies have shown that RA was inversely associated with the risk of AD [27]. RA and/or nonsteroidal anti-inflammatory drugs (NSAIDs) used for the treatment of RA have been considered to be one of the risk factors for AD [23]. However, observational studies are prone to bias such as reverse causation and residual confounding, thereby precluding a clear understanding of the protective effect of RA on AD [17, 22].
Mendelian randomization (MR) is a technique that uses genetic variants as instrumental variables (IVs) to assess whether an observational association between a risk factor or exposure and an outcome is consistent with a causal effect [6]. A two-sample MR estimates causal effects, in which the exposure and outcome data are measured in different samples [20]. It is very useful in situations where it is difficult to measure the exposure and outcome in the same set of individuals [20]. The aim of this study was to examine whether RA is causally associated with AD using a two-sample MR analysis.
Materials and methods
Data sources and selection of genetic variants
We used publicly available summary statistics datasets consisting of three-stage trans-ethnic, European-specific, and Asian-specific genomewide association study (GWAS) meta-analyses, from which we evaluated 10 million single nucleotide polymorphisms (SNPs) in 29,880 RA cases and 73,758 controls assigned as exposures [24]. The summary statistics from a meta-analysis of four GWAS datasets consisting of 17,008 AD cases and 37,154 controls of European ancestry were genotyped and imputed with 7,055,881 SNPs as outcomes [19]. For our two-sample MR study, we used genetic variants associated with RA as IVs to improve inference. We obtained summary statistics (β coefficients and standard errors [SE]) for 80 SNPs associated with RA as IVs from three gout GWAS datasets [24]. In addition, we utilized summary data for 80 AD-associated SNPs from GWAS as outcomes [19].
Statistical analysis for Mendelian randomization
MR analysis requires genetic variants to be related to, but not potential confounders of, an exposure [5]. First, we assessed the independent association of 80 SNPs with RA. Second, we examined the association between each SNP and risk of AD. Third, we combined these findings to estimate the uncompounded causal association between RA and risk of AD using MR analysis. We performed a two-sample MR, which is a method used to estimate the causal effect of an exposure (RA) on outcomes (AD) using summary statistics from different GWAS datasets [15]. In order to assess the causal relationships between RA and Alzheimer’s disease risk, we used summary data from GWAS on RA and AD along with their respective 80 SNPs, which were used as IVs.
The inverse-variance weighted (IVW) method uses a meta-analysis approach to combine the Wald ratio estimates of the causal effect obtained from different SNPs and provides a consistent estimate of the causal effect of the exposure on the outcome when each of the genetic variants satisfy the assumptions of an IV [26]. Although the inclusion of multiple variants in an MR analysis results in increased statistical power, it has the potential to include pleiotropic genetic variants that are invalid IVs [15]. To explore and adjust for pleiotropy (association of genetic variants with more than one variable), the weighted median and MR-Egger regression methods were performed. MR-Egger regression analysis accounts for the presence of unbalanced pleiotropy by introducing a parameter for this bias, thereby incorporating summary data estimates of causal effect from multiple individual variants, which is robust to invalid instruments [2]. MR-Egger is a weighted linear regression of the gene-outcome coefficients on the gene-exposure coefficients [2]. The slope of this regression represents the estimate of the causal effect and the intercept can be interpreted as an estimate of the average horizontal pleiotropic effect across the genetic variants [7]. The weighted median estimator provides a consistent estimate of the causal effect even when up to 50% of the information contributing to the analysis comes from genetic variants that are invalid IVs [3]. The weighted median estimator has an advantage of retaining greater precision of the estimates over the MR-Egger analysis [3]. Tests were considered statistically significant when P < 0.05. All MR analyses were performed with MRBase platform [16].
Heterogeneity and sensitivity test
We assessed the heterogeneities between SNPs using Cochran’s Q statistics and funnel plots [10]. We also performed a “leave one out” analysis to investigate the possibility of causal association being driven by a single SNP. We performed a subgroup analysis using only IV SNPs at a genome-wide significance for sensitivity test.
Results
Studies included in the meta-analysis
Instrumental variables for Mendelian randomization
We selected 80 SNPs as IVs from the GWAS data on RA and 60 of those which were associated with RA had genome-wide significance (supplementary data). Forty-six of all SNPs were inversely associated with AD, and the association with 10 SNPs was statistically significant (supplementary data).
Mendelian randomization results
The IVW method supported an inverse causal association between RA and AD (β = −0.039, SE = 0.017, P = 0.021; Table 1; Figs. 1 and 2). The intercept represents the average pleiotropic effect across the genetic variants (the average direct effect of a variant with the outcome). If the intercept differs from zero (the MR-Egger test), then there is evidence for directional pleiotropy. MR-Egger regression revealed that directional pleiotropy was unlikely to have a bias on the results (intercept = 0.002; P = 0.649). The MR-Egger analysis showed no causal association between RA and AD (β = −0.050, SE = 0.030, P = 0.096; Table 1; Figs. 1 and 2). However, weighted median approach supported a causal association between RA and AD (β = −0.078, SE = 0.024, P = 0.001; Table 1; Fig. 2). The inverse association between RA and AD was not consistent with MR-Egger and weighted median methods. The IVW and weighted median methods suggest a negative causal effect of RA on AD risk, whereas the MR-Egger method suggests a null causal effect. Considering that the weighted median estimator has the advantage of retaining greater precision of the estimates compared to the MR-Egger analysis [3], the results of MR analysis may support an inversely causal association between RA and AD.
Heterogeneity and sensitivity test
Cochran’s Q test indicated evidence of heterogeneity between IV estimates based on the individual variants, but funnel test showed a symmetry, indicating no evidence of heterogeneity (Table 1; Fig. 3). Results from a “leave one out” analysis demonstrated that no single SNP was driving the IVW point estimate, except for rs9268839. When the MR analysis was limited to 60 SNPs at genome-wide significance, the results remained significant (weighted median approach β = −0.078, SE = 0.004, P = 0.004).
Discussion
RA has been reported to be a protective factor against the development of AD [23, 27]. It remains unclear whether RA has a causal relationship with AD, as it was previously reported that association of AD with factors like smoking may be a result of bias or confounding factors inherent to observational studies, including nonsteroidal anti-inflammatory drugs (NSAID) use, reverse causation, small study numbers and sizes, and selection biases [17, 22]. We carried out three different estimating methods (inverse variance weighting method, weighted median method, and MR-Egger regression) for the MR analyses. Although the MR estimates using IVW, MR-Egger, and weighted median analysis were not consistent, IVW and weighted median analysis supported an inverse causal association between RA and AD. Considering that the weighted median estimator has the advantage of retaining greater precision in the estimates compared to the MR-Egger analysis [3], this MR analysis indicated a causal role of RA on the risk of Alzheimer’s disease. Thus, our study corroborates the inverse association found in previous observational studies [23, 27].
MR minimizes the possibility of bias inherent to observational studies due to residual confounding or reverse causality [29]. The genetic variant may be associated with multiple phenotypes, a phenomenon known as pleiotropy, which may result in a confounded estimate from MR and may potentially lead to biased causal estimates [25]. Although the inclusion of multiple variants in MR analyses typically lead to an increased statistical power, it also results in the potential inclusion of pleiotropic genetic variants that are invalid IVs [30]. Therefore, approaches used in sensitivity analyses need to be applied to ensure the validity of conclusions drawn from the MR study. To eliminate pleiotropy, we employed a weighted median estimator, which provides valid estimates even in the case of 50% of SNPs being invalid instruments [3], as well as using an MR-Egger regression to test for unbalanced pleiotropy and to determine the causal estimate exposure’s influence on the outcome [2]. The MR-Egger approach showed no evidence of unbalanced pleiotropy and no causal association between RA and AD. However, the MR-Egger method results in a loss of precision and power [28]. The weighted median estimator is greater in precision of the estimates compared to the MR-Egger analysis. Our weighted median estimator results were similar to those of the IVW estimator, thereby strengthening our confidence in these associations. Our data support the previous observational studies, which have shown an inverse association between RA and AD. Current findings may provide an opportunity to find the underlying mechanisms of the effects of RA on the AD risk factors.
Certain plausible mechanisms could predict how RA is linked to the occurrence of AD. First, the inverse incidence rates between RA and AD cases might be explained by the deregulation of intrinsic cellular and molecular regulators of the inflammatory cascades [13]. Granulocyte macrophage colony stimulating factor (GM-CSF), highly produced in RA synovitis, can induce the differentiation of myeloid cells into specializing cells such as microglia [4]. GM-CSF overexpression could act on bone marrow-derived microglia, transforming them into a proper amyloid-clearing factory to remove amyloid deposition [4]. Moreover, GM-CSF seems to have a trophic effect on neuronal cells, such as enhancing cerebral performance including short-term memory skills [4]. Second, balance in the pathways of interleukin-6 and microRNA-146a is likely to play a critical role in controlling the incidence of AD in treated RA patients [1, 11, 12, 14].
This MR study differs from a previous MR study on the causal relationship between RA and AD risk performed by Policicchio et al. [27], because our data were obtained from the trans-ethnic GWAS meta-analysis of European and Asian subjects, which increased statistical power due to an increased sample size. Our findings on the protective effects of RA on the occurrence of AD are not consistent with those of Policicchio and group. Therefore, this discrepancy indicates a need for further MR studies on this subject.
The present study has several limitations. First, genetic variants have a modest effect on RA, as they only explain a very small proportion of variance in a particular exposure [31]. This means that a very large number of cases are required to detect a causal relationship for the outcome of interest. Second, it is important to ensure that there is a strong relationship between the genetic variant and an exposure. “Weak instrument bias,” which refers to a genetic variant that does not have a sufficiently strong association with the exposure, may affect this MR analysis [8]. However, the sensitivity test performed to limit our analysis of SNPs at a genome-wide significance did not change our results. Third, the AD study was based on participants of European ancestry. As causality may depend on ethnicity and selection bias, further MR studies are needed for other populations for a holistic understanding.
In conclusion, the MR analysis suggested the inverse association between RA and AD. Considering that the weighted median estimator has the advantage of retaining greater precision in the estimates compared to the MR-Egger analysis, the results of MR analysis supported that RA was causally associated with a reduced risk of AD.
References
Baxter D, McInnes IB, Kurowska-Stolarska M (2012) Novel regulatory mechanisms in inflammatory arthritis: a role for microRNA. Immunol Cell Biol 90(3):288–292
Bowden J, Davey Smith G, Burgess S (2015) Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 44(2):512–525
Bowden J, Davey Smith G, Haycock PC et al (2016) Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol 40(4):304–314
Boyd TD, Bennett SP, Mori T et al (2010) GM-CSF upregulated in rheumatoid arthritis reverses cognitive impairment and amyloidosis in Alzheimer mice. J Alzheimers Dis 21(2):507–518
Burgess S, Butterworth A, Thompson SG (2013) Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol 37(7):658–665
Burgess S, Daniel RM, Butterworth AS et al (2014) Network Mendelian randomization: using genetic variants as instrumental variables to investigate mediation in causal pathways. Int J Epidemiol 44(2):484–495
Burgess S, Thompson SG (2017) Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol 32(5):377–389
Burgess S, Thompson SG, Collaboration CCG (2011) Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol 40(3):755–764
Edwards C, Cooper C (2006) Early environmental factors and rheumatoid arthritis. Clin Exp Immunol 143(1):1–5
Egger M, Smith GD, Phillips AN (1997) Meta-analysis: principles and procedures. BMJ 315(7121):1533–1537
Eriksson UK, Pedersen NL, Reynolds CA et al (2011) Associations of gene sequence variation and serum levels of C‑reactive protein and interleukin-6 with Alzheimer’s disease and dementia. J Alzheimers Dis 23(2):361–369
Ferraccioli G, Bracci-Laudiero L, Alivernini S et al (2010) Interleukin-1β and interleukin-6 in arthritis animal models: roles in the early phase of transition from acute to chronic inflammation and relevance for human rheumatoid arthritis. Mol Med 16(552):11–12
Ferraccioli G, Carbonella A, Gremese E et al (2012) Rheumatoid arthritis and Alzheimer’s disease: genetic and epigenetic links in inflammatory regulation. Discov Med 14(79):379–388
Geekiyanage H, Jicha GA, Nelson PT et al (2012) Blood serum miRNA: non-invasive biomarkers for Alzheimer’s disease. Exp Neurol 235(2):491–496
Hartwig FP, Davies NM, Hemani G et al (2016) Two-sample Mendelian randomization: avoiding the downsides of a powerful, widely applicable but potentially fallible technique. Oxford University Press, Oxford
Hemani G, Zheng J, Wade K et al (2016) MR-Base: a platform for systematic causal inference across the phenome using billions of genetic associations. bioRxiv 16:78972
Hill HA, Kleinbaum DG (2000) Bias in observational studies. Encyclopedia of Biostatistics
Kukull WA, Higdon R, Bowen JD et al (2002) Dementia and Alzheimer disease incidence: a prospective cohort study. Arch Neurol 59(11):1737–1746
Lambert J‑C, Ibrahim-Verbaas CA, Harold D et al (2013) Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat Genet 45(12):1452
Lawlor DA (2016) Commentary: two-sample mendelian randomization: opportunities and challenges. Int J Epidemiol 45(3):908
Lee YH, Bae S‑C, Choi SJ et al (2012) Genome-wide pathway analysis of genome-wide association studies on systemic lupus erythematosus and rheumatoid arthritis. Mol Biol Rep 39(12):10627–10635
Lee YH, Bae SC, Song GG (2013) Hepatitis B virus (HBV) reactivation in rheumatic patients with hepatitis core antigen (HBV occult carriers) undergoing anti-tumor necrosis factor therapy. Clin Exp Rheumatol 31:118–121
McGeer PL, Schulzer M, McGeer EG (1996) Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer’s disease: a review of 17 epidemiologic studies. Neurology 47(2):425–432
Okada Y, Wu D, Trynka G et al (2014) Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506(7488):376
Paaby AB, Rockman MV (2013) The many faces of pleiotropy. Trends Genet 29(2):66–73
Pierce BL, Burgess S (2013) Efficient design for Mendelian randomization studies: subsample and 2‑sample instrumental variable estimators. Am J Epidemiol 178(7):1177–1184
Policicchio S, Ahmad AN, Powell JF et al (2017) Rheumatoid arthritis and risk for Alzheimer’s disease: a systematic review and meta-analysis and a Mendelian Randomization study. Sci Rep 7(1):12861
Rees J, Wood AM, Burgess S (2017) Extending the MR-Egger method for multivariable Mendelian randomization to correct for both measured and unmeasured pleiotropy. Stat Med 36(29):4705–4718
Smith GD, Ebrahim S (2008) Mendelian randomization: genetic variants as instruments for strengthening causal inference in observational studies
Smith GD, Ebrahim S (2004) Mendelian randomization: prospects, potentials, and limitations. Int J Epidemiol 33(1):30–42
Swerdlow DI, Kuchenbaecker KB, Shah S et al (2016) Selecting instruments for Mendelian randomization in the wake of genome-wide association studies. Int J Epidemiol 45(5):1600–1616
Acknowledgements
This study was supported in part by a grant from the Korea Healthcare technology R&D Project, Ministry for Health and Welfare, Republic of Korea (HI15C2958).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
S.-C. Bae and Y.H. Lee declare that they have no competing interests.
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Redaktion
U. Müller-Ladner, Bad Nauheim
U. Lange, Bad Nauheim
Caption Electronic Supplementary Material
Rights and permissions
About this article
Cite this article
Bae, SC., Lee, Y.H. Causal association between rheumatoid arthritis and a decreased risk of Alzheimer’s disease. Z Rheumatol 78, 359–364 (2019). https://doi.org/10.1007/s00393-018-0504-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00393-018-0504-8